AU Stock MarketDetailed Quotes
BDX BCAL Diagnostics Ltd
- 0.105
- -0.005-4.55%
20min DelayNot Open Nov 19 15:31 AET
37.66MMarket Cap-4038P/E (Static)
0.110High0.105Low3.86KVolume0.110Open0.110Pre Close406.00Turnover0.18552wk High0.00%Turnover Ratio358.66MShares0.08552wk Low-0.026EPS TTM21.93MFloat Cap0.275Historical HighLossP/E (Static)208.81MShs Float0.051Historical Low-0.026EPS LYR4.55%Amplitude--Dividend TTM4.38P/B1Lot Size--Div YieldTTM
About BCAL Diagnostics Ltd Company
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.
Company Profile
SymbolBDX
Company NameBCAL Diagnostics Ltd
Founded2010
MarketASX
Fiscal Year Ends06-30
AddressQueen Victoria Building GPO Box Q128
CitySydney
CountryAustralia
Zip Code1230
Share RegistryAUTOMIC REGISTRY SERVICES
Level 1, 45 Clarence Street, SYDNEY, NSW, AUSTRALIA, 2000
13 25 83
Company Executives
- Name
- Position
- Salary
- Jayne Andrea Shaw
- Executive Chairman,Executive Director
- --
- Mark Douglas Irving Burrows
- Non-Executive Director
- --
- Jonathan Alfred Grey Trollip
- Non-Executive Director
- --
- John Hurrell
- Non-Executive Director
- --
- David George Darling
- Non-Executive Director
- --
- Ronald (Ron) Anthony Phillips
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data